S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RIGL Rigel Pharmaceuticals Inc

22.75

0.97 (4.45%)

Feb 28 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals Inc News

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update
Tuesday 25 February 2025 (4 days ago) • PR Newswire (US)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 5 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

More Rigel Pharmaceuticals Inc News Articles

Moon Equity (PK)

RespireRx Pharmaceuticals (CE)

Global Developments (PK)

Lightwave Logic

Northwest Biotherapeutics (QB)

NioCorp Developments

CyberFuels (PK)

Good Vibrations Shoes (PK)

TPT Global Tech (PK)

Decentral Life (PK)

Adia Nutrition (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions